ALS Centre CHU Dupuytren
Foundation year2005
DirectorProf. Philippe Couratier
Principal investigatorProf. Philippe Couratier
- Care missions: – Provide diagnosis of motoneuron diseases – Conduct multidisciplinary evaluation every 3 monthsProvide medical and social support – Organize home support
- Training missions: – Organize training actions for the medical and paramedical staff – Share specific knowledges on ALS patient’s care – Participate in and get involved in working groups during the coordination symposium of French ALS centres
- Research missions: – Ensure clinical research activities through the establishment of internal and multicenter research protocols: area of research: epidemiology, cognition and nutrition – Participate in therapeutic research in collaboration with the pharmaceutical industry – Communicate the results of research through oral or displayed communications – Publish the results of research into national and international levels.
Contact Information
AddressLimoges2 Avenue Martin Luther-King87000 France
Phone330555056559
Restricted information
Serving population
1.200.000
Patient resources
Population based register
Clinic based register
Geographically matched controls
Number of muscle samples
10
Number of skin samples
20
Number of brain samples
10
Banks
TypeALS PatientsControlsOther
DNA bank
100
0
100
Serum bank
100
100
100
Research activities
Clinical management research
Neuro epidemiology
Neuro physiology
Neuro imaging
Neuro psychology
Neuro pathology
Genomics
Transcriptomics
Metabolomics
Publication
- Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: A population-based study. Vasta R, Boumédiene F, Couratier P, Nicol M, Nicoletti A, Preux PM, Marin B; Fralim Consortium.. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):24-31.
- Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial. Gonzalez-Bermejo J, Morélot-Panzini C, Tanguy ML, Meininger V, Pradat PF, Lenglet T, Bruneteau G, Forestier NL, Couratier P, Guy N, Desnuelle C, Prigent H, Perrin C, Attali V, Fargeot C, Nierat MC, Royer C, Ménégaux F, Salachas F, Similowski T. Lancet Neurol. 2016 Nov;15(12):1217-1227. doi: 10.1016/S1474-4422(16)30233-2.
- Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriers. Caroppo P, Camuzat A, De Septenville A, Couratier P, Lacomblez L, Auriacombe S, Flabeau O, Jornéa L, Blanc F, Sellal F, Cretin B, Meininger V, Fleury MC, Couarch P, Dubois B, Brice A, Le Ber I. Alzheimers Dement (Amst). 2015 Oct 30;1(4):481-6.
- Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, Copetti M, Preux PM, Beghi E. Int J Epidemiol. 2016 May 16.
- Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis. Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, Nicol M, Raymondeau M, Desport JC, Preux PM, Couratier P; French register of ALS in Limousin (FRALim). Neurodegener Dis. 2016;16(3-4):225-34.